Kybella Cost Guide
Kybella pricing is easy to misunderstand because some practices quote by vial, others quote by session, and the number of treatments varies from person to person. The most useful question is not simply “What does Kybella cost?” but “What will my complete treatment plan require?”
There is no single universal price for Kybella. The American Society of Plastic Surgeons reports an average professional cost of $1,157 for nonsurgical fat reduction overall, a category that includes Kybella but is not Kybella-specific. A more Kybella-specific consumer cost guide from CareCredit reports an average of about $640 per vial, with published prices varying substantially by market. Your total Kybella cost depends mainly on how many vials are used per visit and how many visits your anatomy and goals require.
If you found an old Kybella article quoting a price from several years ago, that number may no longer be useful. Product costs, local market pricing, package structures, and the way practices quote treatment have changed. More importantly, two people can receive completely different Kybella estimates even at the same practice because the treatment plan is based on anatomy.
There are several ways to answer this because different sources measure different things.
| Cost benchmark | Published figure | What it actually means |
|---|---|---|
| ASPS nonsurgical fat reduction average | $1,157 | A national professional-fee average across nonsurgical fat-reduction procedures, not Kybella alone. |
| CareCredit Kybella vial estimate | About $640 per vial | A Kybella-specific published estimate; the same guide reports a broad vial range of $492 to $1,150. |
| CareCredit California Kybella estimate | About $1,988 | A published statewide treatment-cost estimate, useful as context rather than a quote for any individual practice. |
These numbers are best treated as benchmarks, not promises. The American Society of Plastic Surgeons notes that its average does not necessarily represent the entire treatment cost and that location, provider qualifications, and treatment requirements influence pricing.
For a local quote, the most important thing is to compare the same unit of pricing. A $700 “Kybella price” could mean one vial, one session, a promotional rate, or part of a package. Those are not equivalent.
Kybella contains deoxycholic acid and is injected into submental fat beneath the chin. The current U.S. prescribing information states that treatment is mapped across the submental area, with the number and location of injections tailored to the individual patient’s fat distribution and goals.
That is why vial count matters. A smaller treatment area may require less product than a broader or more pronounced area of submental fullness. The final cost therefore depends less on the fact that someone is “getting Kybella” and more on the actual amount of treatment needed.
This is often the largest variable. Vial count is based on the size and distribution of the fat beneath the chin, the shape of the jaw and neck, and the treatment plan created after an in-person assessment.
Kybella is not necessarily a one-visit treatment. The official prescribing information permits up to six treatments spaced at least one month apart. That does not mean every patient needs six sessions; it means total cost cannot be understood from a per-session number alone.
If your main question is timing rather than price, see our separate guide on how long Kybella results take and how long they can last.
Submental fullness can come from more than one anatomical issue. Fat volume, skin laxity, chin projection, neck anatomy, and prior procedures can all affect whether Kybella is the right treatment and how much product may be appropriate.
This distinction matters financially. If loose skin is the dominant issue, repeatedly adding more fat-reduction treatment may not address the actual concern. Our double-chin treatment comparison explains how fat-reduction and skin-tightening options differ.
Cosmetic treatment prices vary significantly by city and region. Los Angeles-area practices may price differently from clinics in smaller markets because staffing, overhead, demand, and practice structure differ.
Provider qualifications and experience also matter. Kybella is not simply a product purchase: safe treatment depends on correct patient selection, knowledge of submental anatomy, proper injection placement, and an appropriate treatment plan.
This is where many comparisons go wrong. A practice offering a lower per-vial price can still produce a higher total quote if more vials are included. Another practice may publish a higher single-vial price but offer a lower package rate for a multi-vial plan.
Before comparing two quotes, write down the number of vials, number of planned visits, package terms, and total expected cost. Then compare like with like.
Kybella used for cosmetic reduction of submental fullness is generally considered an elective aesthetic treatment, so health insurance typically does not cover it. Financing options vary by practice and lender.
If financing matters to your decision, compare the total financed amount and repayment terms, not only the monthly payment.
No. Cost matters, but it should not be separated from the treatment plan.
The official Kybella label emphasizes that safe and effective use depends on correct injection number and location, proper needle placement, and an understanding of relevant submental anatomy. It also identifies risks including marginal mandibular nerve injury, difficulty swallowing, bruising, tissue injury, and other injection-site reactions.
In other words, the meaningful comparison is not simply “Who sells the cheapest vial?” It is “Who has evaluated whether I am a good candidate, how much treatment I actually need, and whether another approach would make more sense?”
For a fuller candidacy discussion, see what to know before deciding whether Kybella is right for you.
Kybella’s active ingredient is deoxycholic acid. Randomized, placebo-controlled clinical trials of ATX-101, the development name for deoxycholic acid injection, found meaningful reductions in submental fat compared with placebo. One phase III study reported significantly higher clinician-rated response and patient satisfaction in treated groups, while treatment-area adverse effects were common and generally temporary.
The FDA-approved indication is specifically for improving the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The current label states that safe and effective use for fat outside the submental area has not been established and is not recommended.
Before agreeing to a price, make sure the quote answers these questions:
Those questions make different providers’ prices much easier to compare and reduce the chance of choosing a seemingly inexpensive option that turns out to require a larger total treatment plan.
Prices vary widely by practice and market. CareCredit’s published Kybella cost guide reports an average of about $640 per vial, with a broad reported range from $492 to $1,150. Treat those figures as market context rather than a quote.
There is no single total because the number of vials and sessions varies. The most accurate estimate comes from multiplying the planned product amount across the expected number of visits, while accounting for any package structure.
Quotes may use different units. One may be per vial, another per session, and another for a package. Geography, provider experience, product amount, and the number of planned visits can also change the total.
Cosmetic Kybella treatment is generally not covered by health insurance because it is elective.
Sometimes, but not always. A modest Kybella plan can cost less than surgery, while a multi-session plan using several vials can narrow the difference. The better comparison includes anatomy, expected result, downtime, treatment count, and total cost, not price alone.